Additional Information
Book Details
Abstract
For more than 30 years, the highly regarded Secrets Series® has provided students and practitioners in all areas of health care with concise, focused, and engaging resources for quick reference and exam review. Nephrology Secrets, 4th Edition, features the Secrets’ popular question-and-answer format that also includes lists, tables, and an easy-to-read style – making reference and review quick, easy, and enjoyable.
- The proven Secrets® format gives you the most return for your time – concise, easy to read, engaging, and highly effective.
- Covers the full range of essential topics in nephrology for in-training or practicing professionals.
- Written and fully updated by global experts and thought leaders in nephrology.
- Top 100 Secrets and Key Points boxes provide a fast overview of the secrets you must know for success in practice and on exams.
- New chapters on home dialysis, onco-nephrology, and palliative care nephrology.
- Fully updated throughout, with clear illustrations, figures, and flow diagrams that expedite study and review.
Table of Contents
Section Title | Page | Action | Price |
---|---|---|---|
Front Cover | Cover | ||
Front matter | i | ||
Nephrology secrets | i | ||
Copyright | ii | ||
Dedication | iii | ||
Contributors | v | ||
Preface | xii | ||
Table of Contents | xiii | ||
Top 100 secrets | xviii | ||
I Patient Assessment | 1 | ||
1 History and physical diagnosis | 3 | ||
Bibliography | 8 | ||
2 Urinalysis | 9 | ||
Bibliography | 21 | ||
3 Measurement of glomerular filtration rate | 22 | ||
Bibliography | 29 | ||
4 Kidney imaging techniques | 30 | ||
Bibliography | 36 | ||
5 Kidney biopsy | 37 | ||
Bibliography | 40 | ||
6 Epidemiology, etiology, pathophysiology, and diagnosis | 43 | ||
Bibliography | 52 | ||
II Acute Kidney Injury | 43 | ||
7 Management options: Continuous renal replacement therapy | 53 | ||
Bibliography | 58 | ||
8 Hepatorenal syndrome | 59 | ||
Bibliography | 61 | ||
9 Cardiorenal syndrome | 69 | ||
Background | 69 | ||
Management | 71 | ||
Pharmacological treatment approach | 71 | ||
Ultrafiltration for cardiorenal syndrome type 2 | 72 | ||
Renal replacement therapy | 74 | ||
Bibliography | 77 | ||
10 Medications | 78 | ||
Drugs covered | 78 | ||
Bibliography | 83 | ||
11 Sepsis | 84 | ||
Bibliography | 88 | ||
12 Rhabdomyolysis | 89 | ||
Bibliography | 93 | ||
13 Contrast-induced nephropathy | 94 | ||
Bibliography | 98 | ||
14 Acute glomerulonephritis and rapidly progressive glomerulonephritis | 99 | ||
Bibliography | 104 | ||
15 Nephrotic syndrome | 105 | ||
Bibliography | 109 | ||
16 Obstructive uropathy | 110 | ||
Bibliography | 112 | ||
17 Nephrolithiasis | 113 | ||
Bibliography | 113 | ||
18 Epidemiology, etiology, pathophysiology, and staging of chronic kidney disease | 119 | ||
Bibliography | 129 | ||
III Chronic Kidney Disease | 119 | ||
19 Anemia in chronic kidney disease | 130 | ||
Bibliography | 134 | ||
20 Bone and mineral metabolism | 136 | ||
Bibliography | 143 | ||
21 Cardiovascular disease | 144 | ||
Bibliography | 148 | ||
22 Dyslipidemia | 150 | ||
Bibliography | 150 | ||
23 Nutrition | 156 | ||
Bibliography | 160 | ||
24 Clinical management of chronic kidney disease | 162 | ||
Bibliography | 168 | ||
25 Drug dosing in patients with chronic kidney disease | 169 | ||
Bibliography | 177 | ||
IV Primary Glomerular Disorders | 179 | ||
26 Minimal change disease | 181 | ||
Bibliography | 184 | ||
27 Focal segmental glomerulosclerosis | 186 | ||
Bibliography | 191 | ||
28 Membranous nephropathy | 192 | ||
Bibliography | 197 | ||
29 Immunoglobulin a nephropathy and henochschönlein disease | 198 | ||
Bibliography | 202 | ||
30 Membranoproliferative glomerulonephritis | 204 | ||
Bibliography | 208 | ||
31 Diabetic kidney disease | 209 | ||
Bibliography | 215 | ||
V Secondary Glomerular Disorders | 209 | ||
32 Lupus nephritis | 216 | ||
Bibliography | 222 | ||
33 Vasculitides | 223 | ||
Bibliography | 227 | ||
34 Streptococcal- and staphylococcal-related glomerulonephritis | 229 | ||
Bibliography | 236 | ||
VI Infection-Associated Glomerulonephritides | 229 | ||
35 Viral hepatitis-associated glomerulonephritis | 237 | ||
Bibliography | 243 | ||
36 Human immunodeficiency virusassociated kidney disorders | 244 | ||
Bibliography | 249 | ||
37 Onconephrology | 251 | ||
Bibliography | 262 | ||
VII Onconephrology | 251 | ||
38 Tumor lysis syndrome | 263 | ||
Bibliography | 266 | ||
39 Dysproteinemias or light chain diseases | 267 | ||
Bibliography | 278 | ||
40 Kidney neoplasias | 279 | ||
Bibliography | 282 | ||
41 Thrombotic microangiopathies | 283 | ||
Bibliography | 286 | ||
42 Fabry disease | 287 | ||
Bibliography | 292 | ||
VIII OTHER RENAL PARENCHYMAL DISEASES | 287 | ||
43 Cystic diseases of the kidneys | 293 | ||
Bibliography | 305 | ||
44 Other hereditary kidney disorders | 307 | ||
Bibliography | 310 | ||
45 Tubulointerstitial diseases | 311 | ||
Acute tubulointerstitial nephritis | 311 | ||
Chronic tubulointerstitial nephritis | 314 | ||
Bibliography | 320 | ||
46 Urinary tract infection | 321 | ||
Bibliography | 327 | ||
IX Kidney Diseases in Special Populations | 329 | ||
47 Kidney disease and hypertension in pregnancy | 331 | ||
Bibliography | 335 | ||
48 Sickle cell nephropathy | 336 | ||
Bibliography | 340 | ||
49 Kidney diseases in the elderly | 342 | ||
Bibliography | 347 | ||
50 Kidney diseases in african americans | 348 | ||
Controversy | 351 | ||
Bibliography | 351 | ||
X Treatment Options | 353 | ||
51 Hemodialysis | 355 | ||
Technical aspects of hemodialysis | 355 | ||
Assessing the dose of dialysis | 358 | ||
Complications of hemodialysis | 360 | ||
Bibliography | 363 | ||
52 Home dialysis | 363 | ||
Bibliography | 366 | ||
53 Peritoneal dialysis | 368 | ||
Technical aspects of peritoneal dialysis | 368 | ||
Assessing the dose of dialysis | 377 | ||
Complications of peritoneal dialysis | 381 | ||
Bibliography | 386 | ||
54 Therapeutic plasma exchange (plasmapheresis) | 387 | ||
Bibliography | 390 | ||
XI Transplantation | 393 | ||
55 Epidemiology and outcomes | 395 | ||
Bibliography | 398 | ||
56 Donor and recipient evaluation | 399 | ||
Bibliography | 402 | ||
57 Immunosuppression | 405 | ||
Bibliography | 409 | ||
58 Rejection of the kidney transplant | 410 | ||
Bibliography | 414 | ||
59 Posttransplant malignancies | 415 | ||
Bibliography | 417 | ||
60 Posttransplant infections | 418 | ||
Bibliography | 419 | ||
61 Primary care of the kidney transplant recipient | 424 | ||
Bibliography | 427 | ||
XII Hypertension | 429 | ||
62 Primary hypertension | 431 | ||
Bibliography | 436 | ||
63 Kidney parenchymal hypertension | 438 | ||
Bibliography | 442 | ||
64 Renovascular disease | 444 | ||
Bibliography | 448 | ||
65 Endocrine hypertension | 449 | ||
Hyperaldosteronism | 449 | ||
Cushing syndrome and congenital adrenal hyperplasia | 451 | ||
Pheochromocytoma | 455 | ||
Bibliography | 459 | ||
66 Other forms of secondary hypertension | 460 | ||
Bibliography | 463 | ||
67 Resistant hypertension | 464 | ||
Drug interactions | 467 | ||
Bibliography | 469 | ||
68 Hypertensive emergencies | 471 | ||
Bibliography | 476 | ||
69 Pharmacologic treatment of hypertension | 477 | ||
Bibliography | 482 | ||
70 Nonpharmacologic treatment of hypertension | 483 | ||
Bibliography | 485 | ||
XIII Acid-Base and Electrolyte Disorders | 487 | ||
71 Volume disorders and assessment | 489 | ||
Volume | 489 | ||
Hypervolemia | 490 | ||
Hypovolemia | 496 | ||
Bibliography | 500 | ||
72 Genetic disorders of sodium transport | 501 | ||
Bibliography | 509 | ||
73 Dysnatremias | 510 | ||
Bibliography | 518 | ||
74 Hypokalemia and hyperkalemia | 519 | ||
Bibliography | 525 | ||
75 Hypocalcemia and hypercalcemia | 526 | ||
Acknowledgment | 531 | ||
Bibliography | 531 | ||
76 Disorders of phosphorus metabolism | 532 | ||
Normal phosphorus physiology | 532 | ||
Hypophosphatemia | 533 | ||
Hyperphosphatemia | 535 | ||
Bibliography | 538 | ||
77 Disorders of magnesium metabolism | 539 | ||
Normal magnesium physiology | 539 | ||
Hypomagnesaemia | 542 | ||
Hypermagnesemia | 545 | ||
Bibliography | 548 | ||
78 Metabolic acidosis | 549 | ||
Metabolic acidosis | 549 | ||
Background and key physiology | 549 | ||
Clinically relevant approach to a patient with metabolic acidosis | 551 | ||
Specific disorders: The anion gap acidoses | 557 | ||
Specific disorders: The non-anion gap acidoses | 564 | ||
Laboratory data | 568 | ||
Acknowledgments | 568 | ||
Bibliography | 568 | ||
79 Metabolic alkalosis | 569 | ||
Introduction and physiology | 569 | ||
Clinical examples of metabolic alkalosis | 573 | ||
Clinical approach | 574 | ||
Acknowledgments | 576 | ||
Bibliography | 576 | ||
XIV Palliative Care in Nephrology | 577 | ||
80 Palliative care in nephrology | 579 | ||
Overview of palliative care and role in nephrology care | 579 | ||
Symptom management | 580 | ||
Support shared decision making | 581 | ||
Advance care planning (ACP) | 583 | ||
Bibliography | 585 | ||
81 Nephrology beginnings | 589 | ||
Bibliography | 595 | ||
Index | 596 | ||
A | 596 | ||
B | 600 | ||
C | 602 | ||
D | 607 | ||
E | 608 | ||
F | 609 | ||
G | 609 | ||
H | 610 | ||
I | 614 | ||
J | 615 | ||
K | 615 | ||
L | 616 | ||
M | 616 | ||
N | 618 | ||
O | 620 | ||
P | 621 | ||
Q | 624 | ||
R | 624 | ||
S | 625 | ||
T | 627 | ||
U | 628 | ||
V | 629 | ||
W | 630 | ||
X | 630 | ||
Y | 630 | ||
Z | 630 |